InsiderExecutive Chairman

Joel S Marcus Insider Trading Activity

Every SEC Form 4 transaction reported by Joel S Marcus, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Joel S Marcus buying or selling?

Joel S Marcus reported 10 open-market buys ($5.5M) and 55 sells ($98.0M) across 65 Form 4 filings at 6 companies — a net selling position of $92.4M.

Source: SEC EDGAR Form 4

What stands out

Key Statistics (as of Sep 15, 2026)

Total Form 4 filings
65
SEC EDGAR
Companies
6
Buys (10)
$5.5M
Sells (55)
$98.0M

Insider sentiment

Net selling

Net insider flow of $92.4M in net selling, filed between Feb 5, 2018 – Sep 15, 2026.

Companies Joel S Marcus files for

#CompanyForm 4 filings
1AREALEXANDRIA REAL ESTATE EQUITIES, INC.41
2ITCIIntra-Cellular Therapies, Inc.11
3ATRAAtara Biotherapeutics, Inc.4
4KRROFrequency Therapeutics, Inc.4
5APLTApplied Therapeutics Inc.3
6MGTXMeiraGTx Holdings plc2

Recent Joel S Marcus transactions

DateTickerRoleTypeSharesValueFiling
Sep 15, 2026AREExecutive ChairmanPurchase5.0K$248.4KSEC ↗
Aug 19, 2026AREExecutive ChairmanPurchase5.0K$231.4KSEC ↗
May 7, 2026AREExecutive ChairmanPurchase7.5K$347.6KSEC ↗
May 6, 2026AREExecutive ChairmanPurchase7.5K$320.4KSEC ↗
May 5, 2026AREExecutive ChairmanPurchase10.0K$410.2KSEC ↗
Feb 13, 2026AREExecutive ChairmanPurchase25.0K$1.3MSEC ↗
Feb 28, 2024AREExecutive ChairmanSale7.5K$891.9KSEC ↗
Feb 28, 2024ITCIDirectorSale26.3K$1.8MSEC ↗
May 10, 2023AREExecutive ChairmanSale7.5K$916.5KSEC ↗
Feb 9, 2023AREExecutive ChairmanSale9.0K$1.5MSEC ↗
Dec 21, 2022ITCIDirectorSale5.0K$254.1KSEC ↗
Dec 14, 2022AREExecutive ChairmanSale6.5K$975.0KSEC ↗
Dec 7, 2022AREExecutive ChairmanSale2.5K$380.0KSEC ↗
Nov 8, 2022ITCIDirectorSale10.0K$523.0KSEC ↗
Aug 12, 2022ITCIDirectorSale10.0K$592.2KSEC ↗
May 13, 2022ITCIDirectorSale10.0K$550.0KSEC ↗
Mar 10, 2022ITCIDirectorSale20.0K$1.1MSEC ↗
Aug 11, 2021AREExecutive ChairmanSale7.5K$1.6MSEC ↗
Aug 4, 2021AREExecutive ChairmanSale5.0K$1.0MSEC ↗
Jul 30, 2021AREExecutive ChairmanSale20.0K$4.0MSEC ↗
Jun 15, 2021ITCIDirectorSale18.3K$773.1KSEC ↗
May 5, 2021AREExecutive ChairmanSale20.0K$3.6MSEC ↗
Mar 4, 2021ITCIDirectorSale15.3K$532.7KSEC ↗
Dec 22, 2020KRRODirectorSale49.7K$1.7MSEC ↗
Aug 19, 2020AREExecutive ChairmanSale7.5K$1.3MSEC ↗

Showing the 25 most recent filings of 65. Screen every filing.

Joel S Marcus insider trading FAQ

Is Joel S Marcus buying or selling?

Across 65 SEC Form 4 filings, Joel S Marcus reported 10 open-market purchases totaling $5.5M and 55 sales totaling $98.0M — a net selling position of $92.4M.

Which companies does Joel S Marcus file Form 4s for?

Joel S Marcus has reported insider transactions at 6 companies, most often ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE), Intra-Cellular Therapies, Inc. (ITCI), Atara Biotherapeutics, Inc. (ATRA), Frequency Therapeutics, Inc. (KRRO), Applied Therapeutics Inc. (APLT).

How far back does Joel S Marcus's filing history go?

Trabud holds Joel S Marcus's SEC Form 4 filings from Feb 5, 2018 – Sep 15, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Joel S Marcus's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Joel S Marcus and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener